Related Experiment Video

Updated: May 23, 2026

A Periprosthetic Joint Candida albicans Infection Model in Mouse
04:37

A Periprosthetic Joint Candida albicans Infection Model in Mouse

Published on: February 2, 2024

Daptomycin resistance in prosthetic joint infections

Brahman Sivakumar1, Praveen Vijaysegaran, Alex Chaudhuri

  • 1Department of Orthopedic Surgery, The Prince Charles Hospital, Chermside, Australia.

Orthopedics
|April 13, 2012
PubMed

Insights

The first reported case of daptomycin-resistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a prosthetic joint infection highlights the growing challenge of antimicrobial resistance. This underscores the urgent need for novel treatments and strategies to combat resistant bacteria.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Orthopedic Surgery

Background:

  • Antimicrobial resistance is a significant global health concern, complicating treatment of bacterial infections.
  • Prosthetic joint infections (PJIs) often necessitate prolonged antibiotic therapy, increasing the risk of resistance development.
  • The emergence of multidrug-resistant organisms poses a serious challenge in clinical practice, particularly in orthopedics.

Observation:

  • This case report details a daptomycin-resistant heterogenous vancomycin intermediate-resistant Staphylococcus aureus (hVISA) infection in an 82-year-old male following elective total knee arthroplasty.
  • The patient developed a deep prosthetic joint infection, which was subsequently treated.
  • This represents the first documented instance of daptomycin resistance in a prosthetic joint infection setting.

Findings:

  • The study identifies and describes a rare case of daptomycin-resistant hVISA.
  • A literature review confirms the increasing prevalence of multidrug-resistant organisms globally.
  • Worldwide reports of hVISA are reviewed, contextualizing the significance of this finding.

Implications:

  • The findings emphasize the critical need for novel antimicrobial agents with unique mechanisms of action.
  • Strategies to mitigate the development and spread of antibiotic resistance are crucial for effective patient management.
  • This case highlights the importance of monitoring antimicrobial susceptibility patterns in orthopedic infections to guide treatment decisions.

More Related Videos

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction10:35

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction

Published on: December 3, 2017

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antibiotic Selection00:57

Antibiotic Selection

Overview